Therapeutic response of cysteamine in the treatment of melasma
DOI:
https://doi.org/10.33448/rsd-v9i6.3468Keywords:
Melasma; Hypermelanosis; Cysteamine.Abstract
The aim of this study was to evaluate how the use of cysteamine in the treatment of melasma has been studied in the literature. This is a qualitative research of the type integrative review to identify productions on topics associated with topical treatment of melasma with cysteamine. The search for the articles was carried out through the Scopus, Science Direct and Pubmed databases using the terms: “melasma” and “cysteamine” and corresponding terms in Portuguese. The research followed the inclusion criteria: a) articles b) be available in full text c) time frame from 01/01/2010 to 31/03/2020 d) studies available in Portuguese, English or Spanish. As exclusion criteria, texts that were unrelated to the theme or had duplicates were disregarded. Of the amount of 11 articles presented, 6 were selected by affinity to the search theme, with 5 articles excluded by the aforementioned criteria. The therapeutic response of cysteamine for the treatment of melasma is positive, reducing hyperpigmented lesions and with controllable adverse effects over the duration of treatment. There was no evidence of the use of cysteamine associated with other active substances or dermatological procedures.
References
Agostinho, G. L. P. L., Oliveira, R. T. G. de, Urzedo, A. P. da S., Cunha, M. G. da, & Machado Filho, C. D. S. (2018). Avaliação comparativa do tratamento de melasma com microagulhamento associado ou não ao drug delivery. Surgical & Cosmetic Dermatology, 10(3), 216–220.
Alster, T. S., & Graham, P. M. (2018). Microneedling: A review and practical guide. Dermatologic Surgery, 44(3), 397–404.
Atallah, C., Charcosset, C., & Greige-Gerges, H. (2020). Challenges for cysteamine stabilization, quantification, and biological effects improvement. Journal of Pharmaceutical Analysis.
Austin, E., Nguyen, J. K., & Jagdeo, J. (2019). Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials. Journal of Drugs in Dermatology, 18(2), 1156–1171.
Braghiroli, C. S., & Conrado, L. A. (2018). Microagulhamento e distribuição transepidérmica de drogas. Surgical & Cosmetic Dermatology, 10(4), 289–297.
Diosti, G. de M., Mulinari-Brenner, F., Neto, J. F., Werner, B., do Nascimento, A., & Piva, F. M. (2012). Avaliação clínica e histológica de pacientes com melasma refratário tratadas com laser de érbio: Yag fracionado. Surgical and Cosmetic Dermatology, 4(1), 114–120.
Farshi, S., Mansouri, P., & Kasraee, B. (2018). Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study. Journal of Dermatological Treatment, 29(2), 182–189.
Grimes, P. E., Ijaz, S., Nashawati, R., & Kwak, D. (2019). New oral and topical approaches for the treatment of melasma. International Journal of Women’s Dermatology, 5(1), 30–36.
Kalil, C. L. P. V., Reinehr, C. P. H., & Milman, L. de M. (2017). Luz Intensa Pulsada: Revisão das indicações clínicas. Surgical and Cosmetic Dermatology, 9(1), 9–16.
Kasraee, B., Mansouri, P., & Farshi, S. (2019). Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman’s formula. Journal of Cosmetic Dermatology, 18(1), 293–295.
Lima, E. D. A. (2015). Microagulhamento em melasma facial recalcitrante: uma série de 22 casos *. Anais Brasileiros de Dermatologia, 90(6), 917–919.
Mansouri, P., Farshi, S., Hashemi, Z., & Kasraee, B. (2015). Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: A randomized double-blind placebo-controlled trial. British Journal of Dermatology, 173(1), 209–217.
McKesey, J., Tovar-Garza, A., & Pandya, A. G. (2019). Melasma Treatment: An Evidence-Based Review. American Journal of Clinical Dermatology.
Miot, L. D. B., Miot, H. A., Da Silva, M. G., & Marques, M. E. A. (2009). Fisiopatologia do melasma. Anais Brasileiros de Dermatologia, 84(6), 623–635.
Ni, Z., Mu, Y., & Gulati, O. (2002). Treatment of melasma with Pycnogenol®. Phytotherapy Research, 16(6), 567–571.
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da Pesquisa Científica. [e-book]. Ed. UAB/NTE/UFSM. Santa Maria/RS. Disponível em:
http://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-PesquisaCientifica.pdf?sequence=1. Acesso em: 05 Abril 2020.
Pinto, C. A. S., Delfes, M. F. Z., Reis, L. M. dos, Garbers, L. E., Passos, P. C. V. da R., & Torre, D. S. de. (2015). Uso do pycnogenol no tratamento do melasma. Surgical & Cosmetic Dermatology, 7(3), 218–222.
Souza, M. T. de, Silva, M. D. da, & Carvalho, R. de. (2010). Revisão integrativa: o que é e como fazer. Einstein, 8(1), 102–106.
Spadafora, M. C. F. de A., Pereira, Ma. D., Leite, R. S., Yoshida, E. H., & Santos, N. S. dos. (2019). Os benefícios dos despigmentantes para o tratamento do melasma e rejuvenescimento facial. Revista Saúde Em Foco, 599–608.
Steiner, D., Arantes, C., Buzzoni, B., Vinicius, T., Cunha, R., & Urano, A. (2011). Melasma e laser fracionado não ablativo ( 1540nm ): um estudo prospectivo. Surgical & Cosmetic Dermatology, 3(1), 37–40.
Steiner, D., Feola, C., Bialeski, N., & de Morais e Silva, F. A. (2009). Tratamento do melasma: Revisão sistemática. Surgical and Cosmetic Dermatology, 1(2), 87–94.
Wanick, F. B. F., Zink, B. S., & Lopes, R. F. (2011). Avaliação da eficácia do licopeno , beta- caroteno e Lactobacillus johnsonii no tratamento de manutenção do melasma durante o verão : um estudo comparativo. Surgical & Cosmetic Dermatology, 3(4), 297–301.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
